Mr. Chair, I'd like to bring forth my motion that I put on notice last week. I'll read it into the record.
I move:
That the Committee report to the House of Commons that it asks the Auditor General to undertake a value for money and performance audit on the work done by McKinsey & Company on behalf of the federal government and Crown corporations since 2015, including the Business Development Bank of Canada (BDC), and also on the effectiveness of BDC spending more broadly since 2021.
The reason I'm bringing this motion forward is that there are a couple of issues. We've heard in the press, of course, about the massive increase of contract money to McKinsey and their tight links with the current government. There's taxpayers' money going to a company linked to rather unsavoury practices, for lack of better words and to be polite, such as the spread of fentanyl and the marketing of opioids through OxyContin, and their rather unsavoury ties with despotic regimes around the world.
I think we owe it to Canadians and to taxpayers that the Auditor General bring forth information on whether this money was spent well, but also, in the broader scope, why we are employing companies that, again, have such unsavoury business practices. We saw the $150-million fine, I think it was, for the marketing, through Purdue—the pharmaceutical company—for OxyContin.
We'd just like to have the Auditor General look into this for us.